Notice of System Recovery: System maintenance has been completed. We deeply apologize for the inconvenience caused by exceeding the scheduled completion time.
Product Document Searching Made Easy by 2D Code! | TCI Chemistry News July 2025 | [Product Highlights] Travoprost with Intra-Ocular-... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
请选择数量
CAS RN: 698387-09-6 | 產品號碼: N1062
Neratinib

* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準,敬請留意。
產品號碼 | N1062 |
純度/分析方法 ![]() |
>95.0%(T)(HPLC) |
分子式 / 分子量 | C__3__0H__2__9ClN__6O__3 = 557.05 |
外觀與形狀(20°C) | Solid |
儲存條件 ![]() |
Frozen (<0°C) |
應避免的情況 | Heat Sensitive |
包裝和容器 ![]() |
100MG-Glass Bottle with Plastic Insert (閲覽圖片) |
CAS RN | 698387-09-6 |
Reaxys-RN | 9971763 |
PubChem Substance ID | 468592465 |
MDL編號 | MFCD09752958 |
產品規格
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 95.0 area% |
Purity(Volumetric Analysis) | min. 95.0 % |
Melting point | 182.0 to 186.0 °C |
NMR | confirm to structure |
性質
熔點 | 184 °C |
GHS
圖形表示 |
![]() |
信號詞 | Warning |
危險性說明 | H302 + H312 + H332 : Harmful if swallowed, in contact with skin or if inhaled. H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P261 : Avoid breathing dust/ fume/ gas/ mist/ vapors/ spray. P270 : Do not eat, drink or smoke when using this product. P271 : Use only outdoors or in a well-ventilated area. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P362 + P364 : Take off contaminated clothing and wash it before reuse. P332 + P313 : If skin irritation occurs: Get medical advice/ attention. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. P302 + P352 + P312 : IF ON SKIN: Wash with plenty of water.Call a POISON CENTER/doctor if you feel unwell. P304 + P340 + P312 : IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/doctor if you feel unwell. |
相關法規
運輸資料
HS編碼* | 2933.49-000 |
Application
Neratinib: A Receptor Tyrosine Kinase Inhibitor of HER1 (EGFR), HER2 and HER4
Neratinib (HKI-272) is a receptor tyrosine kinase inhibitor that irreversibly binds to epidermal growth factor receptors HER1 (EGFR), HER2, and HER4. It has been reported that neratinib reduces EGFR and HER-2 receptor autophosphorylation with inhibition of cell proliferation and functions. Neratinib is highly active against HER2-overexpressing human breast cancer cell lines, and have been mainly used in the treatment of breast cancer. (The product is for research purpose only.)
References
- Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase
- Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity
- The development of HKI-272 and related compounds for the treatment of cancer (a review)
- Neratinib: First Global Approval (a review)
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。